
Kāhu.AI is a New Zealand-based startup developing AI technology to assist doctors in the discovery and diagnosis of skin cancer. Leveraging one of the largest known databases of skin lesions, combined with next-generation AI and a customer-centric approach involving physicians in North America, Australia, and New Zealand, their product aims to improve patient safety and healthcare efficiency. Their primary product, Skin Assist, uses a convolutional neural network to analyze lesion attributes against their extensive database. The company has partnered with research institutions and healthcare providers to ensure their technology is evidence-backed, safe, and effective, with a mission to provide instant skin cancer detection capabilities to every doctor.

Kāhu.AI is a New Zealand-based startup developing AI technology to assist doctors in the discovery and diagnosis of skin cancer. Leveraging one of the largest known databases of skin lesions, combined with next-generation AI and a customer-centric approach involving physicians in North America, Australia, and New Zealand, their product aims to improve patient safety and healthcare efficiency. Their primary product, Skin Assist, uses a convolutional neural network to analyze lesion attributes against their extensive database. The company has partnered with research institutions and healthcare providers to ensure their technology is evidence-backed, safe, and effective, with a mission to provide instant skin cancer detection capabilities to every doctor.